Dear Editor,Bipolar disorder (BD) is a chronic and disabling disorder characterized by manic, hypomanic, or depressive episodes, with an estimated lifetime prevalence ranging from 1% to 5%. Globally, it is a leading c...Dear Editor,Bipolar disorder (BD) is a chronic and disabling disorder characterized by manic, hypomanic, or depressive episodes, with an estimated lifetime prevalence ranging from 1% to 5%. Globally, it is a leading cause of disability and a socioeconomic burden.展开更多
基金the Science and Technology Department of Zhejiang Province(No.2017C37037)the National Key Research and Development Program of China(Nos.2016YFC1307100 and 2018YFC1314200)+1 种基金the Zhejiang Provincial Natural Science Foundation of China(Nos.LQ20H090012 and LQ20H090010)the Zhejiang University Special Scientific Research Fund for COVID-19 Prevention and Control(No.2020XGZX046),China。
基金the Science and Technology Department of Zhejiang Province(No.2017C37037)the National Natural Science Foundation of China(No.81801340)the Zhejiang Provincial Natural Science Foundation of China(Nos.LQ18H090001 and LQ20 H090016)。
基金supported by the National Key Basic Research Program (2016YFC1307100 and 2016YFC1307102)the National Clinical Research Center for Mental Health Disorders (2015BAI13B02)a Key Research Project of Zhejiang Province (2015C03040)
文摘Dear Editor,Bipolar disorder (BD) is a chronic and disabling disorder characterized by manic, hypomanic, or depressive episodes, with an estimated lifetime prevalence ranging from 1% to 5%. Globally, it is a leading cause of disability and a socioeconomic burden.